BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25648361)

  • 1. Tacrolimus and the risk of solid cancers after liver transplant: a dose effect relationship.
    Carenco C; Assenat E; Faure S; Duny Y; Danan G; Bismuth M; Herrero A; Jung B; Ursic-Bedoya J; Jaber S; Larrey D; Navarro F; Pageaux GP
    Am J Transplant; 2015 Mar; 15(3):678-86. PubMed ID: 25648361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors.
    Carenco C; Faure S; Herrero A; Assenat E; Duny Y; Danan G; Bismuth M; Chanques G; Ursic-Bedoya J; Jaber S; Larrey D; Navarro F; Pageaux GP
    Liver Int; 2015 Jun; 35(6):1748-55. PubMed ID: 25488375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
    Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
    World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis of chronic kidney disease after liver transplantation--experience from west China.
    Shao ZY; Yan LN; Wang WT; Li B; Wen TF; Yang JY; Xu MQ; Zhao JC; Wei YG
    World J Gastroenterol; 2012 Mar; 18(9):991-8. PubMed ID: 22408361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
    Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ
    Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Delayed Prolonged-Release Tacrolimus Initiation in De Novo Hepatitis C Virus-Negative Orthotopic Liver Transplant Recipients: A Single-Center, Single-Arm, Prospective Study.
    Lladó L; González-Castillo A; Fabregat J; Baliellas C; Ramos E; González-Vilatarsana E; Busquets J; Xiol X
    Ann Transplant; 2019 Jan; 24():36-44. PubMed ID: 30655498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
    Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
    Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome.
    Rodríguez-Perálvarez M; Germani G; Papastergiou V; Tsochatzis E; Thalassinos E; Luong TV; Rolando N; Dhillon AP; Patch D; O'Beirne J; Thorburn D; Burroughs AK
    J Hepatol; 2013 Feb; 58(2):262-70. PubMed ID: 23023010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus exposure after liver transplantation for alcohol-related liver disease: Impact on complications.
    Bardou FN; Guillaud O; Erard-Poinsot D; Chambon-Augoyard C; Thimonier E; Vallin M; Boillot O; Dumortier J
    Transpl Immunol; 2019 Oct; 56():101227. PubMed ID: 31351125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of long-term exposure to tacrolimus on chronic kidney disease after lung transplantation: A retrospective analysis from a single transplantation center.
    Xiong D; Yue B; Ye S; Wang H; Ban L; Chen Y; Lv J; Zhou M; Yin P; Chen J
    Transpl Immunol; 2023 Jun; 78():101810. PubMed ID: 36918103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ''Minimizing tacrolimus'' strategy and long-term survival after liver transplantation.
    Jia JJ; Lin BY; He JJ; Geng L; Kadel D; Wang L; Yu DD; Shen T; Yang Z; Ye YF; Zhou L; Zheng SS
    World J Gastroenterol; 2014 Aug; 20(32):11363-9. PubMed ID: 25170223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of the use of Calcineurin inhibitors in liver transplantation.
    de Mare-Bredemeijer EL; Metselaar HJ
    Best Pract Res Clin Gastroenterol; 2012 Feb; 26(1):85-95. PubMed ID: 22482528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative carcinogenicity of tacrolimus
    Liu D; Youssef MM; Grace JA; Sinclair M
    World J Hepatol; 2024 Apr; 16(4):650-660. PubMed ID: 38689747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.
    Berenguer M; Aguilera V; San Juan F; Benlloch S; Rubin A; López-Andujar R; Moya A; Pareja E; Montalva E; Yago M; de Juan M; Mir J; Prieto M
    Transplantation; 2010 Dec; 90(11):1204-9. PubMed ID: 21068701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus-related adverse effects in liver transplant recipients: its association with trough concentrations.
    Varghese J; Reddy MS; Venugopal K; Perumalla R; Narasimhan G; Arikichenin O; Shanmugam V; Shanmugam N; Srinivasan V; Jayanthi V; Rela M
    Indian J Gastroenterol; 2014 May; 33(3):219-25. PubMed ID: 24740447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low-dose tacrolimus with mycophenolate mofetil on renal function following liver transplantation.
    Hao JC; Wang WT; Yan LN; Li B; Wen TF; Yang JY; Xu MQ; Zhao JC; Wei YG
    World J Gastroenterol; 2014 Aug; 20(32):11356-62. PubMed ID: 25170222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation.
    Forgacs B; Merhav HJ; Lappin J; Mieles L
    Transplant Proc; 2005 May; 37(4):1912-4. PubMed ID: 15919502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.